Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CLS Holdings agrees to sell Spring Mews student block

(Sharecast News) - CLS Holdings announced on Thursday that it has agreed to sell its student accommodation asset at Spring Mews in Vauxhall, London, for £101.1m in cash to a joint venture between Rosethorn Capital Partners and Barings. The London-listed firm said the agreed price was in line with the property's December valuation, and represented an uplift of 8.1% compared to year-end 2023.

Constructed by CLS in 2014 as part of its mixed-use Spring Mews development, the student block had historically maintained full occupancy, aside from the pandemic period, and delivered record profits in 2024 following a refurbishment.

Completion of the sale was expected in May.

The company said the disposal would enable it to restructure upcoming debt maturities.

Proceeds would be used to repay £85.8m of debt secured against New Printing House Square in Holborn and Artesian in Aldgate, which would now be substituted into an existing Aviva Investors portfolio loan.

That loan, fixed at 2.54%, matures in 2030 and 2032.

The refinancing would allow CLS to retire more expensive debt while retaining the favourable terms of the Aviva facility.

CLS said the transaction was expected to be marginally earnings enhancing, reducing the company's pro forma loan-to-value ratio from 50.7% to 47.9% and lowering its year-end cost of debt by over 20 basis points.

"Spring Mews Student has been a very successful development for CLS, and we are pleased that Rosethorn and Barings will become the owners as the scheme enters its next phase as an integral and continuous part of our Spring Mews estate in Vauxhall," said chief executive officer Fredrik Widlund.

"The sale demonstrates CLS' ability to develop, operate and realise value through its structured, proactive approach and, at the same time, deliver on several strategic priorities by addressing upcoming loan maturities and reducing LTV."

At 0842 GMT, shares in CLS Holdings were up 3.46% at 72.94p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.